Public Procurement

Since 1997, Pharmimex JSC is one of the leading pharmaceutical product suppliers in the public sector.

Since 1997, Pharmimex JSC is one of the leading pharmaceutical product suppliers in the public sector.

• x7 high valued nosological systems
- 20% of supply under the Business Program
- Supply of hemophilia, disseminated sclerosis and Gaucher's disease dugs

• National immunizations schedule
- 100% of vaccines supplied for poliomyelitis and hemophiliac infection prophylaxis
- 6.8% of supply under the Immunization Schedule
• HIV prophylaxis and therapy
- 20% of supply under the HIV-Infected Patient Therapy Program

Subject to the drug coverage program, persons entitled to benefits receive some support in 17 constituent entities of the Russian Federation.

- Shares in the Program-scheduled supply market are rated about 10%.

• Orphan disease treatment
- Pharmimex JSC supplies pharmaceutical products for treating patients suffering from 14 of 24 life-threatening and chronic progressive rare (orphan) diseases resulting in shortening of patient's life and patient's disability
- Shares in the regional program-scheduled supply market are rated about 68%